Elsevier

Clinics in Perinatology

Volume 42, Issue 3, September 2015, Pages 613-623
Clinics in Perinatology

Platelet Transfusions in the Neonatal Intensive Care Unit

https://doi.org/10.1016/j.clp.2015.04.009Get rights and content

Section snippets

Key points

  • Although platelet transfusions are currently administered on the basis of platelet counts or platelet mass, the evidence strongly suggests that factors other than the degree of thrombocytopenia determine the bleeding risk.

  • Thus, larger studies are needed to better characterize the platelet function and the hemostatic profile of preterm infants, and their changes over time and in response to illness.

  • It will be important to develop and validate tests that can be used in preterm infants and that

Platelet transfusion practices

Platelet transfusion remains the primary treatment modality for neonatal thrombocytopenia, but there is lack of agreement regarding the platelet count below which a newborn infant should be transfused. Nevertheless, it has been widely accepted that neonates should be transfused at higher platelet counts than older children and adults, and thus platelet transfusions are a frequent intervention in the NICU. In an earlier study of a single NICU in the United States with liberal transfusion

Primary hemostasis in the neonate

Multiple studies evaluating platelet activation and aggregation clearly demonstrated that neonatal platelets are hyporesponsive in vitro to most agonists (including adenosine diphosphate (ADP), epinephrine, collagen, thrombin, and thromboxane analogs), compared with adult platelets.12, 13 The underlying mechanisms responsible for the decreased platelet responses are different for each agonist. Specifically, the lack of response to epinephrine is explained by the presence of fewer α2-adrenergic

Relationship between severity of thrombocytopenia and bleeding risk

The combination of thrombocytopenia and platelet dysfunction in neonates has been invoked as a potential contributor to the high incidence of intraventricular hemorrhage (IVH) in preterm infants. In that regard, several studies have shown an association between thrombocytopenia and IVH, although this does not establish causality. Importantly, most neonates who experience IVH have normal or minimally decreased platelet counts at the time of their bleeds, highlighting the fact that the

Do platelet transfusions decrease the incidence of bleeding?

Platelet transfusions constitute the only readily available specific treatment for thrombocytopenia in neonates. Although platelet transfusions are frequently given to neonates with platelet counts below a certain arbitrary trigger, there is no good evidence to determine which neonate would benefit from a transfusion. In contrast to the multiple platelet transfusion trigger studies that have been performed in thrombocytopenic adults, the only platelet transfusion trigger trial performed in

Current recommendations

At this point, it is clear that additional well designed randomized controlled trials are needed to help identify safe and effective platelet transfusion thresholds for neonates. The PlaNeT-2 study is a large multicenter study conducted in several European countries that is comparing liberal versus restrictive prophylactic platelet transfusion strategies in thrombocytopenic preterm infants (50 vs 25 × 109/L, respectively).37 Approximately 350 infants have been enrolled to date, of a planned

Future directions

Although currently platelet transfusions are administered on the basis of platelet counts or platelet mass, the evidence strongly suggests that factors other than the degree of thrombocytopenia determine the bleeding risk. Thus, larger studies are needed to better characterize the platelet function and the hemostatic profile of preterm infants, and their changes over time and in response to illness. Along these lines, it will also be important to develop and validate tests that can be used in

First page preview

First page preview
Click to open first page preview

References (43)

  • S.E. Wiedmeier et al.

    Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system

    J Perinatol

    (2009)
  • A. Del Vecchio et al.

    Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions

    Transfusion

    (2001)
  • C.D. Josephson et al.

    Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey

    Pediatrics

    (2009)
  • M. Cremer et al.

    Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland

    Transfusion

    (2011)
  • S.J. Stanworth et al.

    Prospective, observational study of outcomes in neonates with severe thrombocytopenia

    Pediatrics

    (2009)
  • M.G. Garcia et al.

    Epidemiologic and outcome studies of patients who received platelet transfusions in the neonatal intensive care unit

    J Perinatol

    (2001)
  • S.J. Israels et al.

    Deficient thromboxane synthesis and response in platelets from premature infants

    Pediatr Res

    (1997)
  • D. Rajasekhar et al.

    Platelet hyporeactivity in very low birth weight neonates

    Thromb Haemost

    (1997)
  • D.G. Corby et al.

    Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine

    Dev Pharmacol Ther

    (1981)
  • B. Gelman et al.

    Impaired mobilization of intracellular calcium in neonatal platelets

    Pediatr Res

    (1996)
  • A. Schlagenhauf et al.

    Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin

    Platelets

    (2010)
  • Cited by (0)

    Disclosures: None.

    View full text